Toxicogenomics: a pivotal piece in the puzzle of toxicological research

Elisavet T Gatzidou1, Athina N Zira, Stamatios E Theocharis

  • 1Department of Forensic Medicine and Toxicology, University of Athens, Medical School, Athens, Greece.

Insights

Toxicogenomics integrates toxicology and genomics to study how toxic agents affect cellular gene expression. This field uses microarray technology for large-scale mRNA analysis, aiding mechanistic and predictive toxicology research.

Area of Science:

  • Toxicogenomics, an interdisciplinary field merging toxicology and functional genomics.
  • Focuses on the interactions between the cellular genome, environmental toxicants, and disease states.

Background:

  • Cellular responses to toxic agents involve altered gene expression patterns.
  • Gene expression is regulated through transcription (DNA to mRNA) and translation (mRNA to proteins).

Purpose of the Study:

  • To review the applications of toxicogenomics in mechanistic and predictive toxicology.
  • To discuss the limitations of toxicogenomic technologies.
  • To briefly report on complementary 'omic' approaches like proteomics and metabonomics.

Main Methods:

  • Utilizes microarray technology for large-scale detection and quantification of mRNA transcripts.
  • Analyzes alterations in mRNA stability and gene regulation.
  • Incorporates proteomics and metabonomics for broader toxicity insights.

Main Results:

  • Toxicogenomics enables large-scale analysis of gene expression changes in response to toxic agents.
  • Microarray technology facilitates the study of mRNA alterations.
  • Proteomics and metabonomics offer complementary global toxicity information.

Conclusions:

  • Toxicogenomics offers significant advantages for toxicological research, particularly in understanding mechanisms and predicting outcomes.
  • Addressing limitations through integrated 'omic' approaches enhances the comprehensive assessment of toxicity.
  • This field is crucial for advancing environmental health and safety assessments.

Related Concept Videos

Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Pharmacogenetics and Pharmacogenomics: Overview01:29

Pharmacogenetics and Pharmacogenomics: Overview

Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...